LivePerson Q2 2023 Earnings Report
Key Takeaways
LivePerson's Q2 2023 financial results showed a total revenue of $97.5 million, which was above the midpoint of their guidance range. The company's adjusted EBITDA was $12.8 million, exceeding the top end of their guidance range. LivePerson signed 69 deals in total, consisting of 33 new and 36 existing customer contracts, including 3 seven-figure deals.
Total revenue was $97.5 million, exceeding the midpoint of prior guidance.
Adjusted EBITDA was $12.8 million, above the top end of guidance.
Signed 69 deals in total, including 33 new and 36 existing customer contracts.
Trailing-twelve-months average revenue per enterprise and mid-market customer increased 14% to $575,000.
LivePerson
LivePerson
Forward Guidance
For the third quarter, LivePerson expects total revenue to range from $97 million to $101 million and adjusted EBITDA to range from $5.9 million to $12.9 million. For full year 2023, LivePerson is narrowing the revenue guidance range to $388 million - $400 million and increasing the adjusted EBITDA guidance range to $19 million - $32 million.
Positive Outlook
- Maintaining the midpoint of full year 2023 revenue guidance at $394M.
- Narrowing the full year 2023 revenue guidance range to $388M - $400M.
- Increasing the full year 2023 Adjusted EBITDA guidance range to $19M - $32M.
- Expecting B2B Core recurring revenue to represent 86% of total revenue for full year 2023.
- Expecting strong growth from WildHealth's core business.
Challenges Ahead
- Third quarter revenue is expected to range from $97M - $101M.
- B2B Core recurring revenue is expected to represent 85% of total revenue in Q3 due to a one-time increase in non-core revenue.
- Third quarter adjusted EBITDA is expected to range from $5.9M - $12.9M.
- Full year 2023 revenue growth (year-over-year) is expected to be (19)% - (16)%.
- Full year 2023 Adjusted EBITDA margin is expected to be 4.9% - 8.0%.